Grant: Project Grant
University of British Columbia
$604,350.00
Role of transcription factor NFAT5 in viral myocarditis: a novel strategy for therapy
EF 2019-20
Résumé
In North America and globally, heart disease is still the leading cause of death. Viral myocarditis (damage of heart muscle cells by viral infection) is an infectious heart disease. Coxsackie-virus is a very common cause of myocarditis, particularly in children and people < 40 years old. This disease can often lead to heart failure and sudden unexpected death. Currently, there is no effective treatment or vaccine available. To develop a treatment, it is essential to first understand how the virus destroys the heart muscle cells during infection.
In our early experiments to identify the genes damaged by viral infection, we found that a gene called NFAT5 may be of importance. The NFAT5 gene is initially known to be protective to our body through study of kidney disease. However, its role in the heart is not known. We found that NFAT5 can protect the heart by enhancing production of protective proteins against coxsackie-virus infection. However, we further found that NFAT5 protein is damaged by viral infection (i.e., the virus cuts the NFAT5 protein into 2 fragments); this damage decreases the ability of heart cells to defend against infection, leading to increased viral growth and heart muscle cell injury. To better understand this mechanism, we will grow mouse heart muscle cells in Petri dishes and replace the full-length NFAT5 gene with NFAT5-fragments in these cells to mimic the viral infection. The anti-viral activities of the cells containing the full-length NFAT5 gene will be compared to those cells that have the NFAT5 fragments. We will also do a similar experiment using genetically modified mice. These studies will help us confirm that virus-caused damage of the NFAT5 gene can increase viral multiplication and lead to heart muscle cell death. Based on these results, we will have a better understanding on why viral infection can cause heart disease and how we can prevent and treat this disease by enhancing NFAT5 protein production in our body.
Programme
Project Grant
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
408619
Name
Yang Decheng
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Cardiovascular System - B: Heart and Circulation
Projecttitle
Role of transcription factor NFAT5 in viral myocarditis: a novel strategy for therapy
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$604,350
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antiviral Therapy; Conditional Knockout Mouse; Crispr/Cas9; Inducible Nitric Oxide Synthase (Inos); Nfat5 Transcription Factor; Nfkb; Viral Myocarditis; Viral Pathogenesis; Viral Protease
Abstract
In North America and globally, heart disease is still the leading cause of death. Viral myocarditis (damage of heart muscle cells by viral infection) is an infectious heart disease. Coxsackie-virus is a very common cause of myocarditis, particularly in children and people < 40 years old. This disease can often lead to heart failure and sudden unexpected death. Currently, there is no effective treatment or vaccine available. To develop a treatment, it is essential to first understand how the virus destroys the heart muscle cells during infection.
In our early experiments to identify the genes damaged by viral infection, we found that a gene called NFAT5 may be of importance. The NFAT5 gene is initially known to be protective to our body through study of kidney disease. However, its role in the heart is not known. We found that NFAT5 can protect the heart by enhancing production of protective proteins against coxsackie-virus infection. However, we further found that NFAT5 protein is damaged by viral infection (i.e., the virus cuts the NFAT5 protein into 2 fragments); this damage decreases the ability of heart cells to defend against infection, leading to increased viral growth and heart muscle cell injury. To better understand this mechanism, we will grow mouse heart muscle cells in Petri dishes and replace the full-length NFAT5 gene with NFAT5-fragments in these cells to mimic the viral infection. The anti-viral activities of the cells containing the full-length NFAT5 gene will be compared to those cells that have the NFAT5 fragments. We will also do a similar experiment using genetically modified mice. These studies will help us confirm that virus-caused damage of the NFAT5 gene can increase viral multiplication and lead to heart muscle cell death. Based on these results, we will have a better understanding on why viral infection can cause heart disease and how we can prevent and treat this disease by enhancing NFAT5 protein production in our body.
Competitiondate
201909
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Yang, Decheng
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $604,350~ $0~